Full Functional Analysis of Long Non-Coding RNAs: Methods and Protocols Haiming Cao Ebook All Chapters
Full Functional Analysis of Long Non-Coding RNAs: Methods and Protocols Haiming Cao Ebook All Chapters
com
https://textbookfull.com/product/functional-
analysis-of-long-non-coding-rnas-methods-and-
protocols-haiming-cao/
The Long and Short Non coding RNAs in Cancer Biology 1st
Edition Erwei Song (Eds.)
https://textbookfull.com/product/the-long-and-short-non-coding-rnas-
in-cancer-biology-1st-edition-erwei-song-eds/
textbookfull.com
https://textbookfull.com/product/functional-proteomics-methods-and-
protocols-xing-wang/
textbookfull.com
https://textbookfull.com/product/the-chemical-biology-of-long-
noncoding-rnas-stefan-jurga/
textbookfull.com
https://textbookfull.com/product/improving-seed-conditioning-1st-
edition-gregg/
textbookfull.com
The Muqaddimah An Introduction to History Ibn Khaldun
https://textbookfull.com/product/the-muqaddimah-an-introduction-to-
history-ibn-khaldun/
textbookfull.com
https://textbookfull.com/product/c-for-financial-markets-1st-edition-
daniel-j-duffy/
textbookfull.com
https://textbookfull.com/product/god-and-international-relations-
christian-theology-and-world-politics-1st-edition-mika-luoma-aho/
textbookfull.com
https://textbookfull.com/product/long-term-systemic-therapy-
individuals-couples-and-families-arlene-vetere/
textbookfull.com
https://textbookfull.com/product/the-professional-practice-of-jungian-
coaching-corporate-analytical-psychology-1st-edition-nada-obrien-
editor/
textbookfull.com
The Fantastic Line Art of Arthur Rackham Rackham
https://textbookfull.com/product/the-fantastic-line-art-of-arthur-
rackham-rackham/
textbookfull.com
Methods in
Molecular Biology 2254
Functional
Analysis of Long
Non-Coding
RNAs
Methods and Protocols
METHODS IN MOLECULAR BIOLOGY
Series Editor
John M. Walker
School of Life and Medical Sciences
University of Hertfordshire
Hatfield, Hertfordshire, UK
Edited by
Haiming Cao
Cardiovascular Branch, National Heart, Lung and Blood Institute, National Institutes of Health,
Bethesda, MA, USA
Editor
Haiming Cao
Cardiovascular Branch
National Heart, Lung and Blood
Institute
National Institutes of Health
Bethesda, MA, USA
This Humana imprint is published by the registered company Springer Science+Business Media, LLC, part of Springer
Nature.
The registered company address is: 1 New York Plaza, New York, NY 10004, U.S.A.
Preface
Although 2% of the human genome is sufficient to encode all protein-coding genes, a vast
majority of the genome can be transcribed giving rise to 60,000 to 100,000 long noncoding
RNAs (lncRNAs). Mounting evidence supports the notion that lncRNAs play a vital role in
diverse biological progresses, and their dysfunctions have been implicated in a growing list of
human diseases. Studying the function of lncRNAs thus has great potential to quickly fill
knowledge gaps in molecular biology and to identify novel therapeutic targets for human
diseases. However, it remains difficult to identify which lncRNAs are important and how
they carry out their functions. The challenges are threefold. First, compared to protein-
coding genes, our current understanding of the sequence-function relationship of lncRNAs
is limited, and it is difficult to deduce the function of lncRNAs based on their primary
sequence. More robust bioinformatics analyses are often needed to select lncRNAs for
downstream experimental interrogation. Second, the annotation of human lncRNAs is far
from complete. Third, lncRNAs often exercise their function through unique mechanisms
and novel approaches, and systems are required to define their functional importance and
molecular mechanisms. For example, most lncRNAs studied so far exert their function
through their protein-binding partners whose identification is crucial to define a lncRNA’s
mechanism of action. Furthermore, most human lncRNAs are non-conserved and new
models are required to define their physiological function. This book addresses these
fundamental challenges by presenting a comprehensive bioinformatic (Chapters 1–8) and
experimental (Chapters 9–21) toolbox for prioritizing, annotating, and functionally analyz-
ing lncRNAs. It is my hope that this book will provide a timely and convenient resource to
facilitate the identification and characterization of disease-associated human lncRNAs,
which would shed light on their role in biology and pathophysiology and ultimately lead
to novel therapeutic approaches targeting lncRNAs for the amelioration of human diseases.
v
Contents
Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v
Contributors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 349
Contributors
MOHAMAD MOUSTAFA ALI • Department of Medical Biochemistry and Cell Biology, Institute
of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
ALEXANDRE AMLIE-WOLF • Penn Neurodegeneration Genomics Center, University of
Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Department of
Pathology & Laboratory Medicine, University of Pennsylvania Perelman School of
Medicine, Philadelphia, PA, USA
JASMINE BARRA • Department of Oncology, Laboratory of RNA Cancer Biology, LKI Leuven
Cancer Institute, KU Leuven-University of Leuven, Leuven, Belgium; Laboratory for
Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium
STEVEN BUSAN • Department of Chemistry, University of North Carolina, Chapel Hill, NC,
USA
J. MAURO CALABRESE • Department of Pharmacology, University of North Carolina at
Chapel Hill, Chapel Hill, NC, USA; Curriculum in Bioinformatics and Computational
Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Lineberger
Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill,
NC, USA; Curriculum in Pharmacology, University of North Carolina at Chapel Hill,
Chapel Hill, NC, USA
HAIMING CAO • Cardiovascular Branch, National Heart, Lung and Blood Institute,
National Institutes of Health, Bethesda, MD, USA
SÍLVIA CARBONELL SALA • Centre for Genomic Regulation (CRG), The Barcelona Institute of
Science and Technology, Barcelona, Catalonia, Spain
MAOSHAN CHEN • Department of Biochemistry and Genetics, La Trobe Institute for
Molecular Science (LIMS), La Trobe University, Melbourne, VIC, Australia; Australian
Centre for Blood Diseases, Alfred Hospital, Monash University, Melbourne, VIC, Australia
YI CHEN • Cardiovascular Branch, National Heart, Lung and Blood Institute, National
Institutes of Health, Bethesda, MD, USA
XI CHENG • Department of Physiology and Pharmacology, University of Toledo College of
Medicine and Life Sciences, Toledo, OH, USA
YANG DING • Biomedical Pioneering Innovation Center (BIOPIC), Beijing Advanced
Innovation Center for Genomics (ICG), Center for Bioinformatics (CBI), Peking
University, Beijing, China; State Key Laboratory of Protein and Plant Gene Research at
School of Life Sciences, Peking University, Beijing, China
JAMES EBERWINE • Department of Systems Pharmacology and Translational Therapeutics,
University of Pennsylvania Perlman School of Medicine, Philadelphia, PA, USA
GE GAO • Biomedical Pioneering Innovation Center (BIOPIC), Beijing Advanced
Innovation Center for Genomics (ICG), Center for Bioinformatics (CBI), Peking
University, Beijing, China; State Key Laboratory of Protein and Plant Gene Research at
School of Life Sciences, Peking University, Beijing, China
DAVID W. GREENING • Department of Biochemistry and Genetics, La Trobe Institute for
Molecular Science (LIMS), La Trobe University, Melbourne, VIC, Australia; Molecular
Proteomics, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia
ix
x Contributors
RODERIC GUIGÓ • Centre for Genomic Regulation (CRG), The Barcelona Institute of
Science and Technology, Barcelona, Catalonia, Spain; Universitat Pompeu Fabra (UPF),
Barcelona, Catalonia, Spain
MICHIAKI HAMADA • AIST-Waseda University Computational Bio Big-Data Open
Innovation Laboratory (CBBD-OIL), Tokyo, Japan; Faculty of Science and Engineering,
Waseda University, Tokyo, Japan; Artificial Intelligence Research Center, National
Institute of Advanced Industrial Science and Technology (AIST), Tokyo, Japan; Institute
for Medical-Oriented Structural Biology, Waseda University, Tokyo, Japan; Graduate
School of Medicine, Nippon Medical School, Tokyo, Japan
TETSURO HIROSE • Graduate School of Frontier Biosciences, Osaka University, Suita, Japan
MAX A. HORLBECK • Department of Cellular and Molecular Pharmacology, University of
California, San Francisco, CA, USA; Howard Hughes Medical Institute, University of
California, San Francisco, CA, USA; California Institute for Quantitative Biomedical
Research, University of California, San Francisco, CA, USA; Center for RNA Systems
Biology, University of California, San Francisco, CA, USA
SAAKSHI JALALI • CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi,
India; Reliance Technology Group, Reliance Industries Limited, Navi Mumbai, India
CHENG-FEI JIANG • Cardiovascular Branch, National Heart, Lung and Blood Institute,
National Institutes of Health, Bethesda, MD, USA
BINA JOE • Department of Physiology and Pharmacology, University of Toledo College of
Medicine and Life Sciences, Toledo, OH, USA
RORY JOHNSON • Department of Medical Oncology, Inselspital, University Hospital,
University of Bern, Bern, Switzerland; Department of Biomedical Research (DBMR),
University of Bern, Bern, Switzerland; School of Biology and Environmental Science,
University College Dublin, Dublin, Ireland; Conway Institute of Biomedical and
Biomolecular Research, University College Dublin, Dublin, Ireland
CHANDRASEKHAR KANDURI • Department of Medical Biochemistry and Cell Biology, Institute
of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
LAN KE • Biomedical Pioneering Innovation Center (BIOPIC), Beijing Advanced
Innovation Center for Genomics (ICG), Center for Bioinformatics (CBI), Peking
University, Beijing, China; State Key Laboratory of Protein and Plant Gene Research at
School of Life Sciences, Peking University, Beijing, China
JESSIME M. KIRK • Invitae Corporation, San Francisco, CA, USA; Department of
Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;
Curriculum in Bioinformatics and Computational Biology, University of North Carolina
at Chapel Hill, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center,
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
PAVEL P. KUKSA • Penn Neurodegeneration Genomics Center, University of Pennsylvania
Perelman School of Medicine, Philadelphia, PA, USA; Department of Pathology &
Laboratory Medicine, University of Pennsylvania Perelman School of Medicine,
Philadelphia, PA, USA
JULIEN LAGARDE • Centre for Genomic Regulation (CRG), The Barcelona Institute of
Science and Technology, Barcelona, Catalonia, Spain
CHIEN-YUEH LEE • Penn Neurodegeneration Genomics Center, University of Pennsylvania
Perelman School of Medicine, Philadelphia, PA, USA; Department of Pathology &
Laboratory Medicine, University of Pennsylvania Perelman School of Medicine,
Philadelphia, PA, USA
Visit https://textbookfull.com
now to explore a rich
collection of eBooks, textbook
and enjoy exciting offers!
Contributors xi
VINOD SCARIA • CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi,
India; Academy of Scientific and Innovative Research (AcSIR), CSIR IGIB South
Campus, Delhi, India
FAYAZ SEIFUDDIN • Bioinformatics and Computational Biology, National Heart, Lung, and
Blood Institute National Institutes of Health, Bethesda, MD, USA
RICHARD J. SIMPSON • Department of Biochemistry and Genetics, La Trobe Institute for
Molecular Science (LIMS), La Trobe University, Melbourne, VIC, Australia
AMRITA SINGH • CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi,
India
DANIEL SPRAGUE • Flagship Pioneering, Boston, MA, USA; Department of Pharmacology,
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Lineberger
Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill,
NC, USA; Curriculum in Pharmacology, University of North Carolina at Chapel Hill,
Chapel Hill, NC, USA
LUISA STATELLO • Department of Medical Biochemistry and Cell Biology, Institute of
Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
SANTHILAL SUBHASH • Department of Medical Biochemistry and Cell Biology, Institute of
Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
WITTAYA SUWAKULSIRI • Department of Biochemistry and Genetics, La Trobe Institute for
Molecular Science (LIMS), La Trobe University, Melbourne, VIC, Australia
HARISH SWAMINATHAN • Whitehead Institute, Cambridge, MA, USA
PHILLIP TOMEZSKO • Program in Virology, Harvard Medical School, Boston, MA, USA;
Whitehead Institute, Cambridge, MA, USA
BARBARA USZCZYŃSKA-RATAJCZAK • Institute of Bioorganic Chemistry Polish Academy,
Poznan, Poland
ROBERTO VENDRAMIN • Department of Oncology, Laboratory of RNA Cancer Biology, LKI
Leuven Cancer Institute, KU Leuven-University of Leuven, Leuven, Belgium; Laboratory
for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium
LIGUO WANG • Division of Biomedical Statistics and Informatics, Mayo Clinic College of
Medicine, Rochester, MN, USA; Department of Biochemistry and Molecular Biology, Mayo
Clinic College of Medicine, Rochester, MN, USA
LI-SAN WANG • Penn Neurodegeneration Genomics Center, University of Pennsylvania
Perelman School of Medicine, Philadelphia, PA, USA; Department of Pathology &
Laboratory Medicine, University of Pennsylvania Perelman School of Medicine,
Philadelphia, PA, USA
KEVIN M. WEEKS • Department of Chemistry, University of North Carolina, Chapel Hill,
NC, USA
JONATHAN S. WEISSMAN • Department of Cellular and Molecular Pharmacology, University
of California, San Francisco, CA, USA; Howard Hughes Medical Institute, University of
California, San Francisco, CA, USA; California Institute for Quantitative Biomedical
Research, University of California, San Francisco, CA, USA; Center for RNA Systems
Biology, University of California, San Francisco, CA, USA
RONG XU • Department of Biochemistry and Genetics, La Trobe Institute for Molecular
Science (LIMS), La Trobe University, Melbourne, VIC, Australia
WENTAO XU • Beijing Advanced Innovation Center for Food Nutrition and Human
Health, College of Food Science and Nutritional Engineering, China Agricultural
University, Beijing, China
Contributors xiii
Abstract
There is accumulating evidence that long noncoding RNAs (lncRNAs) play crucial roles in biological
processes and diseases. In recent years, computational models have been widely used to predict potential
lncRNA–disease relations. In this chapter, we systematically describe various computational algorithms and
prediction tools that have been developed to elucidate the roles of lncRNAs in diseases, coding potential/
functional characterization, or ascertaining their involvement in critical biological processes as well as
provide a comprehensive summary of these applications.
1 Introduction
Haiming Cao (ed.), Functional Analysis of Long Non-Coding RNAs: Methods and Protocols, Methods in Molecular Biology,
vol. 2254, https://doi.org/10.1007/978-1-0716-1158-6_1, © Springer Science+Business Media, LLC, part of Springer Nature 2021
1
2 Fayaz Seifuddin and Mehdi Pirooznia
available tools can be classified into three main categories (Table 1),
lncRNA–disease (n = 11), lncRNA–protein function (n = 7), and
coding potential (n = 4), as well as some tools with hybrid func-
tionality (n = 3). Our description of each tool will include a brief
summary of the methods and its utility. We conclude with discuss-
ing the limitations of these computational methods and future
directions of lncRNA function prediction.
(continued)
4
Table 1
(continued)
PADLMHOOI Xuan et al. 31,191,710 2019 Predicting disease-associated LncRNA-MiRNA pairs https://www.ncbi.nlm.nih.gov/pmc/
based on the higher-order orthogonal iteration articles/PMC6525924/
DCSLDA Zhao et al. 30,046,354 2018 Predicting disease-lncRNA associations based on the https://www.ncbi.nlm.nih.gov/pmc/
distance correlation set and information of the articles/pmid/30046354/
miRNAs
SIMCLDA Lu et al. 29,718,113 2018 Predicting potential lncRNA-disease associations based https://github.com//bioinfomaticsCSU/
on inductive matrix completion SIMCLDA
TPGLDA Ding 29,348,552 2018 lncRNA-disease-gene tripartite graph, which integrates https://github.com/USTC-HIlab/
et. Al. gene-disease associations with lncRNA-disease TPGLDA
associations
PMFILDA Xuan et al. 30,744,078 2019 Infers potential lncRNA-disease associations based on https://www.ncbi.nlm.nih.gov/pmc/
the probability matrix decomposition articles/pmid/30744078/
LLCLPLDA Xie G et al. 31,250,107 2019 Locality-constrained linear coding label propagation https://www.ncbi.nlm.nih.gov/pubmed/
strategy 31250107
BPLLDA Xiao et al. 30,459,803 2018 Based on simple paths with limited lengths in a https://www.ncbi.nlm.nih.gov/pmc/
heterogeneous network articles/PMC6232683/
Lnc2Cancer Gao et al. 30,407,549 2019 Queying experimentally supported long non-coding http://www.bio-bigdata.net/lnc2cancer
RNAs in human cancers
TSSR Ou-Yang 31,191,605 2019 LncRNA-disease association prediction using two-side https://github.com/Oyl-CityU/TSSR
et al. sparse self-representation
ProphTools Navarro C 29,186,475 2017 Based on prioritization tools for heterogeneous https://github.com/cnluzon/prophtools
et al. biological networks
RWLPAP Zhao et al. 30,182,833 2018 Random walk for lncRNA-protein associations https://www.ncbi.nlm.nih.gov/pubmed/
prediction 30182833
LPI-ETSLP Hu et al. 28,702,594 2017 lncRNA-protein interaction prediction using eigenvalue https://www.ncbi.nlm.nih.gov/pubmed/
transformation-based semi-supervised link prediction 28702594
LPI-IBNRA Xie et al. 31,057,602 2019 lncRNA-protein interaction prediction based on https://www.ncbi.nlm.nih.gov/pmc/
improved bipartite network recommender algorithm articles/PMC6482170/
LncRRIsearch Fukunaga 31,191,601 2019 Web server for lncRNA-RNA interaction prediction http://rtools.cbrc.jp/LncRRIsearch/
et al. integrated with tissue-specific expression and
subcellular localization data
LnCompare Carlevaro- 31,147,707 2019 Web server tests for enrichment amongst a panel of http://www.rnanut.net/lncompare/
Fita J quantitative and categorical features
et al.
ACCBN Zhu R 30,626,319 2019 Ant-Colony-clustering-based bipartite network method https://github.com/
et al. for predicting long non-coding RNA-protein BioMedicalBigDataMiningLabWhu/
interactions lncRNA-protein-interaction-prediction
SFPEL-LPI Zhang 30,533,006 2018 Sequence-based feature projection ensemble learning for http://www.bioinfotech.cn/SFPEL-LPI/
et al. predicting LncRNA-protein interactions
lncRNAs Functional Prediction Methods and Tools
5
6 Fayaz Seifuddin and Mehdi Pirooznia
2.3 DCSLDA DCSLDA [10] is a novel model based on similarity of disease pairs
and distance correlation to predict potential lncRNA–disease asso-
ciations. It integrates known lncRNA–miRNA associations and
known miRNA–disease associations. In addition, to optimize the
prediction performance of DCSLDA, new methods to calculate the
similarity of disease–disease pairs and lncRNA–lncRNA pairs are
developed simultaneously.
3.5 LnCompare LnCompare [25] is a tool that compares lncRNA genes based on a
comprehensive feature set with more than 100 attributes covering
diverse aspects, including gene structure, nucleotide composition,
evolutionary conservation, cell and tissue expression, subcellular
localization, tissue specificity, repetitive sequence content, and phe-
notypic association. It is comprised of two main modules: (1) gene
set feature comparison which compares two sets of lncRNAs, and
identifies significantly different features, both categorical and quan-
titative; (2) similar gene discovery which uses user-defined gene(s)-
of-interest to query for the set of most similar lncRNAs, based on
one or more features.
4.5 COME Come [32] (coding potential calculator based on multiple evi-
dences), is using a supervised machine learning model trained on
mRNAs and lncRNAs. It is a robust coding potential calculation
tool for lncRNA characterization based on multiple features. It
integrates multiple sequence-derived and experiment-based fea-
tures using a decompose–compose method and substantially
improves the consistency of predication results from other coding
potential calculators.
5 Hybrid Tools
6 Conclusion
References
1. DiStefano JK (1706) The emerging role of updated database of long non-coding RNA-as-
long noncoding RNAs in human disease. sociated diseases. Nucleic Acids Res 47(D1):
Methods Mol Biol 2018:91–110 D1034–D1037
2. Jalali S, Kapoor S, Sivadas A, Bhartiya D, Scaria 7. Chen X, Sun YZ, Guan NN, Qu J, Huang ZA,
V (2015) Computational approaches towards Zhu ZX, Li JQ (2019) Computational models
understanding human long non-coding RNA for lncRNA function prediction and functional
biology. Bioinformatics 31(14):2241–2251 similarity calculation. Brief Funct Genomics 18
3. Zhang Y, Huang H, Zhang D, Qiu J, Yang J, (1):58–82
Wang K, Zhu L, Fan J, Yang J (2017) A review 8. Yu J, Ping P, Wang L, Kuang L, Li X, Wu Z
on recent computational methods for predict- (2018) A novel probability model for LncRNA
ing noncoding RNAs. Biomed Res Int ( )disease association prediction based on the
2017:9139504 naive Bayesian classifier. Genes (Basel) 9
4. Lalevee S, Feil R (2015) Long noncoding (7):345
RNAs in human disease: emerging mechanisms 9. Xuan Z, Feng X, Yu J, Ping P, Zhao H, Zhu X,
and therapeutic strategies. Epigenomics 7 Wang L (2019) A novel method for predicting
(6):877–879 disease-associated LncRNA-MiRNA pairs
5. Wapinski O, Chang HY (2011) Long noncod- based on the higher-order orthogonal itera-
ing RNAs and human disease. Trends Cell Biol tion. Comput Math Methods Med
21(6):354–361 2019:7614850
6. Bao Z, Yang Z, Huang Z, Zhou Y, Cui Q, 10. Zhao H, Kuang L, Wang L, Xuan Z (2018) A
Dong D (2019) LncRNADisease 2.0: an novel approach for predicting disease-lncRNA
12 Fayaz Seifuddin and Mehdi Pirooznia